AA
VRX

AlphaMark Advisors’s VALEANT PHARMACEUTICALS INTL VRX Stock Holding History

AlphaMark Advisors’s Portfolio VRX Stock Details VRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-186
Closed -$19K – 342
2015
Q4 		$19K Buy
+186
New +$19K 0.01% 192

Other funds holding VRX

SIM
Sonora Investment Management Tucson, Arizona $798M AUM 17.61% 1-Year Est. Return
TWA
TCI Wealth Advisors Tucson, Arizona $1.88B AUM 21.09% 1-Year Est. Return

AlphaMark Advisors's VRX Position: Q1 2016 in Review

AlphaMark Advisors sold out of VALEANT PHARMACEUTICALS INTL (VRX) in Q1 2016, closing a stake of 186 shares — an estimated $19K sold.

AlphaMark Advisors first reported a position in VRX in Q4 2015 and held it in 1 quarter. The position peaked at $19K in Q4 2015. 2 funds tracked by Wall St. Rank hold VRX as of Q1 2016.

  • AlphaMark Advisors reported no remaining VALEANT PHARMACEUTICALS INTL position as of Q1 2016 after selling out during the quarter.
  • AlphaMark Advisors sold 186 VALEANT PHARMACEUTICALS INTL shares in Q1 2016, an estimated $19K.
  • AlphaMark Advisors first reported a position in VALEANT PHARMACEUTICALS INTL in Q4 2015 and held it in 1 quarter.
  • AlphaMark Advisors's VALEANT PHARMACEUTICALS INTL position peaked at $19K in Q4 2015.
  • 2 funds tracked by Wall St. Rank held VALEANT PHARMACEUTICALS INTL as of Q1 2016.

Based on AlphaMark Advisors's 13F filing for Q1 2016, filed 5 May 2016.